课题基金 / 基金详情

Development of chemoradiotherapy using TAS-102 for rectal cancer

Development of chemoradiotherapy using TAS-102 for rectal cancer
使用TAS-102治疗直肠癌的放化疗的进展
批准号:
20K09051
负责人:
Nishikawa Takeshi
金额:
$2.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2023-03-31

项目摘要

项目成果

Nishikawa Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00384-021-04085-4
发表时间: 2022
期刊: International Journal of Colorectal Disease
影响因子: 2.8
作者: [Ozaki Kosuke, Kawai Kazushige, Nozawa Hiroaki, Sasaki Kazuhito, Murono Koji, Emoto Shigenobu, Abe Hiroyuki, Ushiku Tetsuo, Ishihara Soichiro]
通讯作者: Ishihara Soichiro
Therapeutic effects and limitations of chemoradiotherapy in advanced lower rectal cancer focusing on T4b
以T4b为重点的晚期低位直肠癌放化疗的疗效及局限性
DOI: 10.1007/s00384-021-03936-4
发表时间: 2021
期刊: International Journal of Colorectal Disease
影响因子: 2.8
作者: [Ozaki Kosuke, Kawai Kazushige, Nozawa Hiroaki, Sasaki Kazuhito, Murono Koji, Emoto Shigenobu, Iida Yuuki, Ishii Hiroaki, Yokoyama Yuichiro, Anzai Hiroyuki, Sonoda Hirofumi, Sugihara Kenichi, Ishihara Soichiro]
通讯作者: Ishihara Soichiro
Development of a novel apoptosis-based tumor regression grade to assess the efficacy of preoperative chemoradiotherapy for rectal cancer: a retrospective single-center study
开发一种新的基于细胞凋亡的肿瘤消退等级来评估直肠癌术前放化疗的疗效:一项回顾性单中心研究
DOI: 10.1007/s10147-021-01948-2
发表时间: 2021
期刊: International Journal of Clinical Oncology
影响因子: 3.3
作者: [Ozaki Kosuke, Kawai Kazushige, Nozawa Hiroaki, Sasaki Kazuhito, Murono Koji, Ishihara Soichiro]
通讯作者: Ishihara Soichiro
The inhibition of autophagy potentiates anti-oncogenic and anti-angiogenic effect of sulforaphane by inducing apoptosis
  • 批准号:
    16K07161
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2016
  • 负责人:
    Nishikawa Takeshi
  • 依托单位:
Role of mitochondrial ROS generation in the development of diabetic complications
海外基金